DRKS00009869
Recruiting
Not Applicable
Therapeutic Drug Monitoring in tuberculosis patients. Setup and optimisation of therapeutic drug monitoring at the Research Center Borstel
Medizinische Klinik des Foschungszentrums Borstel0 sites20 target enrollmentJanuary 13, 2016
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- A15.9
- Sponsor
- Medizinische Klinik des Foschungszentrums Borstel
- Enrollment
- 20
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •pan\-susceptible, MDR and XDR Tuberculosis
Exclusion Criteria
- •Currently pregnant or breastfeeding, participation/enrollement not feasible according to a physician, unable to provide informed consent, no consent obtained
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 4
Therapeutic drug monitoring in tocilizumab-treated rheumatoid arthritis patients: Pilot study of a double-blind randomised controlled trialrheumarheumatoid arthritis10003816NL-OMON44574Amsterdam Rheumatology and immunology Center | Reade30
Not yet recruiting
Not Applicable
latent TB in healthcare workersCTRI/2018/11/016432TMA Pai endowment chair Manipal Academy Of Higher Education
Completed
Not Applicable
The Role of Therapeutic Drug Monitoring in Tuberculosis - a Pilot StudyActive TuberculosisNCT02042261Thomas Schon38
Completed
Not Applicable
The effect of monitoring of tobramycin levels in blood in patients with cystic fibrosis.NL-OMON20263AMC35
Not yet recruiting
Phase 4
Test and Treat to End Tuberculosis (TB): A screening and treatment study for children and adults with Latent Tuberculosis Infection (LTBI)atent Tuberculosis InfectiontuberculosisLatent Tuberculosis InfectionRespiratory - Other respiratory disorders / diseasesInfection - Other infectious diseasesPublic Health - EpidemiologyPublic Health - Health service researchACTRN12622000115730Woolcock Institute of Medical Research208,000